| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2862616 | American Journal of Hypertension | 2007 | 8 Pages |
Abstract
The dual ARB/PPARγ agonist telmisartan achieved more microalbuminuria reduction than an ARB with no PPARγ agonistic action, possibly through suppression of the inflammatory state in metabolic hypertensive patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yuichiro Yano, Satoshi Hoshide, Joji Ishikawa, Chishio Noguchi, Daisuke Tukui, Hidaka Takanori, Masashi Tada, Yoshimasa Kanemaru, Ayako Yano, Shizukiyo Ishikawa, Kazuyuki Shimada, Kazuomi Kario,